In-Hospital Delays in Stroke Thrombolysis
- 1 August 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 51 (8), 2536-2539
- https://doi.org/10.1161/strokeaha.120.029468
Abstract
Background and Purpose: Intravenous thrombolysis is a well-established treatment for acute ischemic stroke. Our aim was to quantify the effect of each minute delay in door-to-needle time (DNT) on 90-day survival, intracerebral hemorrhagic complication <36 hours, and functional outcomes at 3 months, in routine clinical practice. Methods: Our nationwide registry-based study included 14 132 adult patient admissions with ischemic stroke receiving intravenous thrombolysis from 2010 to 2017. Outcomes were analyzed using multivariable logistic regression, adjusting for potential confounders. Results: Median DNT was 47 minutes, with an improvement from 65 to 38 minutes during the study. Median age was 74 years, and median National Institutes of Health Stroke Scale 8 points. We found a significant impact of each minute delay in DNT with reduced odds of survival by 0.6%, increased odds of intracerebral hemorrhagic and worse activities of daily living by 0.3%, and worse living conditions and mobility by 0.4%. Conclusions: Improving DNT is a key factor in achieving good outcomes after stroke. We estimate that in Sweden alone in 2017, compared with 2010, the shorter DNT achieved have saved 38 lives, avoided 8 intracerebral hemorrhagic transformations, and spared, respectively, 36, 51, and 52 patients from a worsening in activities of daily living, living conditions, and mobility. DNT is sensitive for interventions and should be targeted in quality improvement efforts.Keywords
This publication has 8 references indexed in Scilit:
- If Time Is Brain Where Is the Improvement in Prehospital Time after Stroke?Frontiers in Neurology, 2017
- Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-StrokeStroke, 2017
- Effects of Alteplase for Acute Stroke on the Distribution of Functional OutcomesStroke, 2016
- Validation of Hospital Performance Measures of Acute Stroke Care Quality. Riksstroke, the Swedish Stroke RegisterNeuroepidemiology, 2016
- Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement InitiativeJAMA, 2014
- Stroke ThrombolysisStroke, 2014
- Systematic review of mass media interventions designed to improve public recognition of stroke symptoms, emergency response and early treatmentBMC Public Health, 2010
- Thrombolysis for acute ischaemic strokePublished by Wiley ,2009